History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Yankees Universe Fund Fred's Team Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck Cookbook
Press Releases Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online
Making an Appointment
Dr. David H. Abramson, Chief, Ophthalmic Oncology Service, and Dr. Murk H. Heinemann, Associate Attending

Most children with retinoblastoma in the United States -- more than 95 percent -- survive the cancer and have normal lives. Children with unilateral retinoblastoma have one eye whose sight is not affected even though they may have had one eye removed. It is important for children with vision in one eye to wear protective eyewear during sports and other activities.

Retinoblastoma is a life-threatening disease, but it is rarely a fatal one if treated appropriately. With the correct treatment and appropriate follow-up both for eyes and for cancers in other parts of the body, the retinoblastoma patient has a very good chance of living a long life.

Follow-Up Care

The majority of children with bilateral retinoblastoma retain at least one eye with good vision and many are able to retain the use of both eyes. However, all children with bilateral disease and the 15 percent of unilateral patients who have the familial form of retinoblastoma will be at much higher risk for other cancers not involving the eyes throughout their lives.

Maria Hinton, nurse practitioner; Harriet Rosengarten, medical secretary; and Diane M. Murphy, Ophthalmic Tech: Nursing

Five years after the initial diagnosis of retinoblastoma, more children with the inherited form of retinoblastoma have died from these second tumors than from the original retinoblastoma. The most common second tumors are osteogenic sarcoma (a cancerous tumor which affects the bones), soft tissue sarcomas, and cutaneous melanomas (tumors of the skin, muscle, and connective tissue).

Although the reported incidences of these tumors vary widely, the risk appears to be about one percent a year. This risk is also increased by the use of external beam radiation, although the amount of increase depends on the age at which the child was treated.

Follow-up appointments with an ophthalmologist and by a pediatric oncologist are very important when a child is diagnosed with retinoblastoma. Frequency of examinations depends upon the age of the child, the ophthalmologist's suspicion of new tumors, whether one or both eyes are involved, and the type of treatment that the child has received. Parents are encouraged to talk to the nurse and to call with questions between visits.

Long-Term Follow-Up Program

To meet the health care needs of childhood cancer survivors, Memorial Sloan-Kettering has developed a unique, multifaceted Long-Term Follow-Up Program, available to children and young adults who have been off treatment for approximately two years. The program offers services including initial follow-up consultations, treatment plans, screening and treatment for late effects, referrals and coordination of health care, and long-term health education.



Last Updated: Jan. 17, 2006
PrintEmail This Page